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Purpose: To assess Alchornea cordifolia, a medicinal plant with numerous biological actions and uses 
in traditional medicine, for possible toxicity in rats.   
Methods: The probable effect of the ethanol extract of Alchornea cordifolia (250 - 2000 mg/kg, p.o.) by 
gavage was evaluated on blood cellular elements and chemistry, as well as on the weight and histology 
of vital organs of male adult Spraque-Dawley rats. 
Results: Daily administration of the extract for two weeks did not cause significant changes in most 
haematological indices and blood chemistry. However, a dose-dependent increase (p < 0.01) in 
neutrophils was observed. Relative organ weights were comparable in control and treated groups. 
Histopathological assessment of liver sections of treated-rats showed normal architecture at doses < 
1000 mg/kg. However, in animals treated with 1000 and 2000 mg/kg, cloudy swelling of hepatocytes 
with vacuolar and hydropic degeneration were evident. Kidney architecture at all dose levels was 
normal.  
Conclusion: The results of the study show that administration of the ethanol extract of Alchornea 
cordifolia to male adult rats by gavage evoked histopathologic changes in the liver at doses > 1000 
mg/kg. These findings call for caution in the use of Alchornea cordifolia especially in high doses.  
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INTRODUCTION 
 
The World Health Organization (WHO) 
estimates that nearly 70 % of the world 
population depend on traditional medicine, 
especially medicinal plants, for their primary 
health care needs [1]. Concerns have, 
however, been raised by researchers 
regarding the safety of such botanical 
products.  Alchornea cordifolia (Schumach 
and Thonn) Müll. Arg. (Euphorbiaceace) is a 
shrub found along the coastal regions of 
West Africa. Traditionally, pulverized leaves 
of Alchornea cordifolia are used to treat 
wounds, sores and cuts [2]. Phytochemical 
analysis of the leaves has identified the 
presence of several compounds including 
flavonoids [3].  Reports on the biological 
activity of Alchornea suggest that it is 
antibacterial [4]
  
 spasmolytic [3], anti-
inflammatory [5], hepato-protective [6],
 
anti-
diarrhoeal [7], antioxidant [8] and 
antimicrobial [9]. We reported previously on 
the propensity of Alchornea alcoholic extract 
to provoke hepatic damage in mice [10]. In 
view of possible interspecies variation in 
response to toxic agents, we were prompted 
to investigate the effect of Alchornea extract 
in rats with the objective of expanding the 
knowledge on the safety profile of this 




Collection and identification of plant 
material 
 
The fresh leaves of the plant Alchornea 
cordifolia were obtained from the Kwame 
Nkrumah University of Science and 
Technology botanical gardens and 
authenticated by Dr. Kofi Annan of the 
Department of Pharmacognosy, Faculty of 
Pharmacy and Pharmaceutical Sciences, 
College of Health Sciences, Kwame Nkrumah 
University of Science and Technology, 
Kumasi, Ghana. A voucher specimen (No. 
FPPS-DCOL. 123) was kept at the herbarium 
of the Department of Pharmacognosy, 
Faculty of Pharmacy and Pharmaceutical 
Sciences, College of Health Sciences, 
Kwame Nkrumah University of Science and 
Technology, Kumasi, Ghana.  
 
Preparation of Alchornea cordifolia 
extract 
 
The leaves of the plant were sun-dried for 
one week and then powdered in a hammer 
mill. The powder (800 g) was extracted by 
cold maceration with 70 % alcohol (5 L). The 
alcohol was evaporated in a rotary 
evaporator attached to a thermochiller (Buchi 
700, Recirculation chiller) at a temperature of 
20 
o
C. The residue was freeze-dried to obtain 
a brown sample of the crude extract (yield: 
10.80 %w/w), subsequently referred to as the 




Male adult Spraque-Dawley rats (130 - 195 g) 
were purchased from Noguchi Memorial 
Institute for Medical Research, University of 
Ghana, Legon, Accra, Ghana and maintained 
in the animal house of the Department of 
Pharmacology, Kwame Nkrumah University 
of Science and Technology, Kumasi, Ghana. 
They were housed in groups of six in 
stainless steel cages (34 x 47 x 18 cm) with 
soft wood shavings as bedding, fed with 
normal commercial pellet diet (GAFCO, 
Tema, Ghana) and given water ad libitum.  
The animals were humanely handled 
throughout the experiment in accordance with 
ethical guidelines for the care of laboratory 
animals (EEC directive of 1986:86/609 EEC) 
[11]. The protocols were approved (Ref. No. 
D/COL/ECA-8-2010) by the Department’s 
Ethics Committee.  
 
Subacute treatment   
 
Male Spraque-Dawley rats (130 - 195 g) were 
obtained and divided into five groups (n = 6). 
The groups received 250, 500, 1000, 2000 
mg/kg extract in 2 % tragacanth (p.o.) daily 
for 2 weeks. The control group received 
tragacanth 2 % only throughout the 2-week 
period. The animals were monitored closely 
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for signs of toxicity, and at the end of the two-
week period, the rats were euthanized by 
cervical dislocation and blood was collected 




Haematological analyses were performed on 
whole blood collected into tubes with 
ethylenediaminetetraacetic acid (EDTA). 
White blood cell (WBC), lymphocytes (LYM), 
mid cells (MID), neutrophils (NEU), red blood 
cells (RBC), haemoglobin concentration (HB), 
haematocrit (HCT), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin 
(MCH), mean corpuscular haemoglobin 
concentration (MCHC), red cells distribution 
weight (RDW) and platelets (PLT)  were 
determined by an automatic analyzer (CELL 
DYN 1700, Abbott Diagnostics Division, 




Biochemical analyses were performed on 
serum obtained after centrifugation of whole 
blood (without anticoagulant) at 3000 rpm for 
5 min. Determination of total proteins; total 
bilirubin, indirect bilirubin, albumin, globulin 
and A/G ratio were performed using an 
automatic analyzer (Random Access 
Chemistry System ATAC 8000, élan 
diagnostic laboratories, Brea, CA, USA). 
Levels of the liver enzymes alanine 
aminotransferase (ALT), alkaline 
phosphatase (ALP) and γ- glutamyl 
aminotransferase (GGT) were also 
determined. Analysis for blood urea nitrogen 
(BUN), creatinine, sodium, potassium and 
chloride were performed as well. 
 
Organ weight determination 
 
The following organs were quickly removed 
and individually weighed: liver, spleen, 
kidneys, heart, stomach, testes and lungs. 
Macroscopic appearances of the organs were 
observed and the relative weight of each 
organ was calculated. The liver and kidney 




For microscopic examination, whole liver and 
kidney were fixed in 10 % neutral buffered 
formalin. Sections (2.0 mm) were placed in 
tissue preparation cassettes and processed 
with an auto processor (Microm STP120, 
Spain) for embedding in paraffin. Tissue 
sections of 7.0 µm were cut and stained with 




Results were expressed as mean ± standard 
error of mean (SEM). Statistical analysis was 
performed by one-way ANOVA using Graph 
Pad Prism for Windows version 4.02 (Graph 
Pad software, San Diego, CA, USA), followed 
by Neuman Keuls test to evaluate significant 
differences between the groups. Differences 




Behavior of the treated animals 
 
When the animals were observed closely 
over the period for signs of toxicity, no 
abnormal behavior, motor or neurological 
disorder was noticed. The treatment did not 
affect the gastrointestinal or respiratory 
systems. There was no mortality or changes 
in locomotor activity. Food and water intake 
were normal and there were no significant 
differences between the body weight of the 
treated and control groups over the 14-day 




For haematological evaluation, there was no 
significant change in most of the parameters 
analyzed (Table 1). However, there was a 
significant dose-dependent increase in the 
neutrophil count of animals treated with the 
extract compared to the control. The level of 
lymphocyte decreased in rats treated with 
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Fig 1:  Weight of rats before (plain bars) and after (striped bars) 14-day treatment with Alchornea cordifolia 
extract.  
 
Table 1: Effect of Alchornea cordifolia on haematological indices in rats treated for two weeks.   
 
Dose (mg/kg)  
Parameter Control 250 500 1000 2000 
WBC (K/µL) 10.34±1.77 8.70±1.01 9.58±0.38 8.88±0.98 8.08±1.20 
LYM (%) 83.63±3.07 81.94±1.11 76.70±1.69 76.52±2.59 71.64±2.35* 
MID (%) 13.03±1.87 13.32±0.35 16.10±0.93 15.62±2.02 17.34±2.00 
NEU (%) 3.35±1.42 4.74±1.01 7.20±0.88* 7.86±0.73* 11.02±0.86** 
RBC (M/µL) 6.01±0.20 5.84±0.07 6.00±0.32 5.98±0.21 5.77±0.14 
HB (g/dL) 13.48±0.51 13.83±0.47 13.02±0.51 13.20±0.40 12.62±0.26 
HCT (%) 35.80±1.43 35.20±0.91 34.75±1.80 34.15±1.09 32.78±0.47 
MCV (fl) 59.62±1.47 59.97±0.96 57.95±0.99 57.12±0.80 56.84±0.66 
MCH (pg) 22.44±0.60 22.98±0.29 21.80±0.54 22.08±0.35 22.16±0.24 
MCHC (g/dL) 37.66±0.57 38.14±0.49 37.58±0.68 38.65±0.10 39.02±0.24 
RDW (%) 15.86±0.66 16.02±0.45 15.30±0.32 14.67±0.29 16.12±0.34 
PLT (K/µL) 276.40±95.49 302.20±60.01 401.70±65.66 348.50±69.70 446.20±99.82 
Values are expressed as means ± SEM ( n = 6); (*) indicates significant (p < 0.05) and ** (p < 0.01) 
compared to control (Newman Keuls test)              
 
Serum biochemical analysis 
 
Biochemical parameters determined did not 
differ from control (Table 2).  Similarly, renal 
function parameters investigated did show 
any differences as compared to the control 
groups. 
 
Relative organ weights 
 
We observed no significant differences 
between the treated groups and the control 
group.    
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Table 2: Effect of Alchornea cordifolia extract on serum biochemistry of rats treated for two 
weeks.  
                                                 
                                          Doses (mg/kg)  
Parameter     Control  250 500 1000 2000 
Total bilirubin 
(µmol/L 
24.97±7.72 47.03±9.21 48.56±20.31 33.52±13.60 63.61±18.00 
Direct bilirubin 
µmol/L 
7.52±1.92 13.11±2.45 13.34±5.76 9.58±3.65 16.76±4.73 
Total protein  (g/L) 87.00±2.30 93.00±4.57 87.20±4.63 86.80±5.54 90.80±1.93 
Albumin (g/L) 38.80±1.59 41.17±1.11 41.60±0.40 38.00±2.55 39.80±1.02 
Globulin (g/L) 4.82±0.27 5.18±0.39 4.56±0.43 4.88±0.37 5.10±0.13 
Albumin/globulin 
ratio 
0.82±0.09 0.82±0.05 0.94±0.08 0.80±0.06 0.78±0.02 
AST (U/L) 206.80±27.32 219.80±15.41 252.80±14.95 212.80±16.93 247.00±22.07 
ALT (U/L) 88.20±17.07 99.50±14.23 116.20±6.67 101.00±5.30 112.40±11.63 
ALP (U/L) 389.80±26.04 282.20±56.42 295.00±9.64 351.00±50.00 282.00±0.00 
GGT (U/L) 9.60±0.51 19.17±5.44 9.67±3.18 10.75±2.10 14.50±3.50 
Values are expressed as means ± SEM (n = 6), no significant differences between control and treated 




There were no changes in the liver of rats 
treated with 250 mg/kg and 500 mg/kg 
extract compared to the control (Figure 2). 
However, in the groups treated with 1000 
mg/kg and 2000 mg/kg extract, we observed 
cloudy swelling of hepatocytes with vacuolar 
and hydropic degeneration respectively. 
These changes were diffuse throughout but 
less severe around the portal tracts as 
depicted in Figure 2 which is a representative 
photomicrograph of six animals 
 
As Fig 3 indicates, examination of the 
kidneys did not show any differences 
between the extract-treated group and control 




The therapeutic potential of natural products 
has increased considerably in recent years 
with renewed awareness that natural 
products have the potential to cause toxicity 




Figure 2: Photomicrograph (x 400) of liver 
sections of rats treated with Alchornea cordifolia 
extract for 14 days. Tissues fixed in 10 % neutral 
buffered formalin were processed and stained with 
hematoxylin and eosin. Panel A shows the liver 
section for vehicle-treated control animals, panel B 
(250 mg/kg), panel C (500 mg/kg), panel D (1000 
mg/kg) and panel E (2000 mg/kg) of extract. In 
panels D and E, cloudy swelling of   hepatocytes 
with vacuolar and hydropic    degeneration are 
seen. The changes are diffused throughout but 
less severe around the portal tracts 
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Figure 3: Photomicrograph (x 400) of kidney 
sections of rats treated with Alchornea cordifolia 
extract for 14 days. Tissues fixed in 10% neutral 
buffered formalin were processed and stained with 
hematoxylin and eosin. Panel A shows the kidney 
section for vehicle-treated control animals, panel B 
(250 mg/kg), panel C (500 mg/kg), panel D (1000 
mg/kg) and panel E (2000 mg/kg) of extract. No 
changes were observed in the treatment groups 
compared to the vehicle-treated control. 
 
 
There has therefore been a growing interest 
in the safety assessment of herbal medicines 
over the past few years. 
 
In the present study, we investigated the 
possible toxicity of Alchornea cordifolia 
extract, a potential medicinal agent in rats. 
Following a 14-day treatment with the extract, 
the animals were closely monitored for signs 
of toxicity. Normally, loss of more than 10 % 
of initial body weight is an indicator of 
adverse effects [13]. In our study, we did not 
find significant changes in the body weight or 
the behavior of the animals. The slight 
increase in body weight after the 14-day 
treatment can be ascribed to normal growth 
of the animals over the period. Food and 
water intake were normal and no deaths 
occurred. The relative weights of vital organs 
of animals did not show significant 
differences compared to the vehicle-treated 
control with no evidence of organ swelling, 
atrophy or hypertrophy in the animals. These 
observations indicate that our treatment had 
no effect on the general condition and 
functional behavior of the animals.  
 
The hematological system has a predictive 
value for toxicity in humans and therefore 
analysis of blood is relevant to risk evaluation 
[14]. Results of the hematological analysis 
showed that Alchornea cordifolia has little or 
no effect on white blood cell (WBC), 
lymphocytes (LYM), mid cells (MID), 
neutrophils (NEU), red blood cells (RBC), 
haemoglobin concentration (HB), haematocrit 
(HCT), mean corpuscular volume (MCV), 
mean corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration 
(MCHC), red cells distribution weight (RDW) 
and platelets (PLT). However, a dose 
dependent increase in neutrophils (NEU) was 
observed. Neutrophils interact with foreign 
compounds and microorganisms and destroy 
them by the process of phagocytosis. 
 
They 
are also known to be involved in the 
pathology of various inflammatory conditions.  
It is plausible that the increase in neutrophils 
in the present study is related to the liver cell 
injury observed in the histopathological 
studies. Lymphocytes are also known to 
circulate in blood and migrate to injured 
tissues. This may account for the decrease in 
lymphocyte numbers at the highest dose of 
treatment.  
 
The markers of renal function, urea and 
creatinine, were assessed based on reported 
kidney toxicity associated with the use of 
medicinal plants [15]. These parameters were 
not affected in treated animals. Alchornea 
cordifolia has been shown to contain 
flavonoids [3]. Some of these flavonoids have 
been demonstrated to inhibit nephrotoxicity 
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because of its strong antioxidant activity [16]. 
Alchornea cordifolia has also been reported 
to contain tannins and tannins are known to 
offer protection against nephrotoxicity [17]. It 
is possible that these constituents offered 
protection to the treated animals in the 
present study. 
 
Aspartate transaminase (AST) and Alanine 
transaminase (ALT) are considered as 
indicators of liver function.  High levels of 
AST, ALT and ALP in serum are usually 
indicative of disease and necrosis in the liver 
of animals.
 
 Alkaline phosphatase (ALP), 
Gamma glutamyl transpeptidase (GGT), 
albumin, globulin, bilirubin and total protein 
were the other biochemical parameters 
analyzed. Analysis of these parameters is 
important since there are several reports of 
liver toxicity related to the use of medicinal 
plant products [18]. These parameters did not 
differ in the treated and the vehicle-treated 
groups, indicating that Alchornea cordifolia 
caused no adverse effect on the hepatic and 
renal systems.  
 
Histopathological observations in the liver 
however did not correlate with the 
biochemical findings especially at high doses 
(1000-2000 mg/kg). At high doses of 
Alchornea treatment, we observed 
degenerations in the liver suggesting early 
signs of liver cell injury. This type of liver 
injury is however known to be reversible upon 
withdrawal of the toxicant allowing the liver 
cells to regenerate. This early stage of liver 
injury may not necessarily reflect in elevation 
of liver enzymes. 
 
In contrast to the present findings, Alchornea 
cordifolia at doses of 200-500 mg/kg was 
reported to protect rats against paracetamol-
induced liver damage [6].
  
Alchornea evoked  
mild liver damage at rather high doses (1000 
- 2000 mg/kg) in the present work. This may 
be intriguing but the extract probably contains 
several components with different 
pharmacological actions. The proportion of 
specific toxicants may be increased at high 
doses. Though the liver damage detected in 
the histopathology studies was not 
associated with corresponding elevation of 
liver transaminases, the potential toxicity of 
the extract especially at high doses cannot be 
ignored.   
 
Estimates based on recommended dosage of 
dried Alchornea cordifolia leaves (maximum 
50 g per litre of water; 4 cups daily) in 
traditional medicine [19] suggest that humans 
could take a maximum of 200 mg/kg of our 
extract daily. Though this appears to be much 
lower than the dosages used in the present 
study, observation of potential liver damage 
in mice previously [10] and the fact that 
dosages in herbal remedies are never 
precise due to non-standardization, call for 




The results of the study indicate that though 
the alcohol extract of Alchornea cordifolia is 
relatively non-toxic to the haematological and 
renal systems, it is potentially hepatotoxic in 
rats if administered at high doses. Though 
these findings cannot be directly extrapolated 
to man in view of possible species 
differences and possible differences in 
metabolic activation, the present results 
suggest that caution should be taken in the 
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